Sassan Momtazbakhsh, MD
Internal Medicine · Tucson, AZNPI 1659461358
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Johnson & Johnson at 40.0% of the total.
Across 14 payments — averaging $86.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$486
- Abbott$166
- Medtronic$159
- Biosense Webster, Inc.$140
- AstraZeneca$102
- Kestra Medical Technology Services, Inc.$95
- plus $68 from 1 others
What the payments were for
- Food & beverage$1,217100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 7 | $486 |
| Abbott | 2 | $166 |
| Medtronic | 1 | $159 |
| Biosense Webster, Inc. | 1 | $140 |
| AstraZeneca | 1 | $102 |
| Kestra Medical Technology Services, Inc. | 1 | $95 |
| Inari Medical, Inc. | 1 | $68 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$228
- NA$159
- MitraClip$147
- NUVISION ICE CATHETER$140
- FARXIGA$102
How this compares
$1,217 in reported general payments places this provider in the 75th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $25,755 |
| TrulicityDulaglutide | 25 | $13,089 |
| JardianceEmpagliflozin | 29 | $10,455 |
| JanuviaSitagliptin Phosphate | 14 | $7,958 |
| Meropenem-0.9% NaclMeropenem-0.9% Sodium Chloride | 18 | $3,880 |
| Midodrine Hcl | 49 | $2,916 |
| MyrbetriqMirabegron | 14 | $2,083 |
| Vancomycin Hcl | 20 | $1,795 |
| Levetiracetam | 41 | $1,594 |
| Oxycodone Hcl | 115 | $1,578 |
| Icosapent Ethyl | 15 | $1,360 |
| LantusInsulin Glargine,hum.Rec.Anlog | 19 | $1,326 |
| Valproic AcidValproic Acid (As Sodium Salt) | 23 | $1,151 |
| Sodium Chloride0.9 % Sodium Chloride | 22 | $1,117 |
| Gabapentin | 61 | $972 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tucson
- Rajesh JanardhananTucson$685K
- Mona SelejTucson$440K
- Franz RischardTucson$55K
- Nebojsa SkrepnikTucson$48K
- Christine OxleyTucson$44K
- Muhammad HusnainTucson$19K
- Steven WoolTucson$19K
- Surekha BandlamuriTucson$17K
- Augusto PosadasTucson$15K
- Lisa EmmansTucson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.